Table of Contents
Licensing
| Neurocrine gains BIAL’s Parkinson’s asset Opicapone for North America | Abstract pdf html |
| Vipul Sikka |
| BMS Expands Collaboration with CytomX for US$200 M Upfront | Abstract pdf html |
| Natasha Piper |
| AstraZeneca Out-licenses US Rights for its COPD Drugs to Circassia | Abstract pdf html |
| Jasmine Kalsi |
Mergers & Acquisitions
| Otsuka Gains Late-Stage ADHD Drug in Neurovance Acquisition | Abstract pdf html |
| Natasha Piper |
| Astellas Acquires Fezolinetant for Menopausal Symptoms in Ogeda Acquisition | Abstract pdf html |
| Natasha Piper |
This work is licensed under a Creative Commons Attribution 3.0 License.